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Abstract
Objective To synthesise the literature on indoor tanning and
non-melanoma skin cancer.
Design Systematic review and meta-analysis.
Data sources PubMed (1966 to present), Embase (1974 to present),
and Web of Science (1898 to present).
Study selection All articles that reported an original effect statistic for
indoor tanning and non-melanoma skin cancer were included. Articles
that presented no data, such as review articles and editorials, were
excluded, as were articles in languages other than English.
Data extraction Two investigators independently extracted data.
Random effects meta-analysis was used to summarise the relative risk
of ever use versus never use of indoor tanning. Dose-response effects
and exposure to indoor tanning during early life were also examined.
The population attributable risk fraction for the United States population
was calculated.
Results 12 studies with 9328 cases of non-melanoma skin cancer were
included. Among people who reported ever using indoor tanning
compared with those who never used indoor tanning, the summary
relative risk for squamous cell carcinoma was 1.67 (95% confidence
interval 1.29 to 2.17) and that for basal cell carcinoma was 1.29 (1.08
to 1.53). No significant heterogeneity existed between studies. The
population attributable risk fraction for the United States was estimated
to be 8.2% for squamous cell carcinoma and 3.7% for basal cell
carcinoma. This corresponds to more than 170 000 cases of
non-melanoma skin cancer each year attributable to indoor tanning. On
the basis of data from three studies, use of indoor tanning before age
25 was more strongly associated with both squamous cell carcinoma
(relative risk 2.02, 0.70 to 5.86) and basal cell carcinoma (1.40, 1.29 to
1.52).
Conclusions Indoor tanning is associated with a significantly increased
risk of both basal and squamous cell skin cancer. The risk is higher with
use in early life (<25 years). This modifiable risk factor may account for
hundreds of thousands of cases of non-melanoma skin cancer each
year in the United States alone and many more worldwide. These findings
contribute to the growing body of evidence on the harms of indoor tanning
and support public health campaigns and regulation to reduce exposure
to this carcinogen.
Introduction
The incidence of basal cell carcinoma and squamous cell
carcinoma of the skin, collectively termed non-melanoma skin
cancer (NMSC), has increased dramatically over previous
decades, in what some have termed an epidemic.
1 2 NMSC is
by far the most common human malignancy, and nearly 30%
of white people living in areas of exposure to high ultraviolet
radiation will develop an NMSC in their lifetime.
3 Because of
its high prevalence, NMSC is a considerable financial burden
to healthcare systems.
4-6
Although NMSC is the most common cancer, it is often
excluded from national cancer registries and cancer databases
because it typically does not affect survival. NMSC is more
common in older men, but more tumours have recently been
documented in women and in younger people of both sexes.
7 8
Besides older age and male sex, major risk factors for
development of NMSC include light skin, family history,
residence at latitudes near the equator, and exposure to
ultraviolet radiation.
9 10
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Research
RESEARCHBecause it is potentially modifiable, indoor tanning is a
particularly important type of exposure to ultraviolet radiation.
IndoortanningisaclassIcarcinogen,considered“carcinogenic
to humans” by the International Agency for Research on
Cancer.
11 Indoor tanning is significantly associated with
increased risk of malignant melanoma and was shown to be a
potential risk factor for NMSC in a previous, smaller
meta-analysis.
12 13 Several studies have examined the link
between NMSC and indoor tanning.
14-29 However, the study
sizesandthepercentageofparticipantsreportingexposurehave
been small, yielding varied results. Our aim in this study was
to synthesise the available data on indoor tanning and NMSC.
Methods
We carried out this review in accordance with the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) guidelines.
30
Literature search
We defined NMSC as either basal cell carcinoma or squamous
cell carcinoma and indoor tanning as the use of an ultraviolet
emission device to produce a cosmetic tan. The terminology
used in the literature is diverse. In this analysis, we considered
indoor tanning, sunbed, sunlamp, tanning bed, tanning booth,
solarium, artificial tanning, artificial ultraviolet tanning,
non-solar ultraviolet tanning, and variations of these to be
synonymous with indoor tanning.
We identified studies through searches of electronic databases
andbyscanningreferencelistsofarticles.WesearchedPubMed
(1966topresent),Embase(1974topresent),andWebofScience
(1898topresent).Twoauthors(MRWandMLS)didthesearch,
and the last search was run on 16 March 2012. Additionally,
we reviewed identified articles and reviews on the topics of
NMSC and ultraviolet exposure closely to locate additional
articles. Specifics of the search strategy used in each database
are detailed in the supplementary materials.
All published articles in English that reported an effect statistic
for indoor tanning and NMSC or that reported measuring or
adjusting for indoor tanning in a study including participants
with NMSC were eligible for inclusion. Two authors (MRW
and MLS) assessed the eligibility of studies by using the title
and abstract for initial screening followed by review of the full
text.Weexcludedarticlesthatpresentednodata,suchasreview
articles and editorials, and articles in languages other than
English. Inclusion criteria for quantitative meta-analysis were
studies reporting an effect estimate, such as an odds ratio or
hazard ratio, or reporting measurement of or adjustment for
indoortanningthatcouldbeusedtocalculateaneffectestimate.
We used a data extraction sheet, which was developed on the
basis of the Cochrane Consumers and Communication Review
Group’s data extraction template. We extracted the following
dataitemsfromeachstudy:characteristicsofstudyparticipants
(including age, sex, type of NMSC) and inclusion/exclusion
criteria, characteristics of study design (including design type,
presence of matching in case-control studies, matching
characteristics, and number of controls per case), outcomes
(including effect estimates of different doses of exposure to
indoor tanning), and statistical methods (including univariate
or multivariate analyses, logistic regressions, and variables
included).
Statistical methods
Fortheprimarymeta-analysis,weusedtheoddsratioorhazard
ratio for ever exposure to indoor tanning, which was the
exposure measure used by most of the studies. Ever exposure
(for example, participants were asked: “Have you ever used an
indoor ultraviolet tanning device to produce a cosmetic tan?”)
was available for 10 studies. For two studies, the only available
measure was “regular” exposure (Bakos et al
17) or greater than
fiveexposuresperyear(Waltheretal
28).Wethusdidtheprimary
analysis on the 10 studies reporting ever exposure and a
subsequent sensitivity analysis that included all 12 studies. In
one instance, we calculated an unadjusted odds ratio and 95%
confidenceintervalfromtherawdataofamatchedstudy.
14Data
comparing ever use versus never use of indoor tanning came
directly from the authors of one study that did not show this
comparison in the manuscript.
29 We also did a sensitivity
analysis excluding four retrospective studies that did not fully
adjust for confounders (see supplementary table).
14 19 21 27
We did additional analyses on studies that reported effect
statistics for high dose exposures and on studies that reported
effect statistics for young age at exposure. High dose exposure
was assessed by four studies, which used exposure measures of
“regularuseoftanningbedsinlifetime,”
176-26yearsofregular
exposure,
20 exposure more than five times per year,
28 and
exposure four times per year.
29 Three studies reported young
age at first exposure, using 16 years of age or younger,
20 less
than 20 years of age,
25 and “high school/college,” which is
typically 14-25 years of age.
29 Although these studies used
differentdosesofexposureforhighdoseexposureanddifferent
cut-off ages for young age, these represent the only and thus
best available data.
WeusedStata11statisticalsoftwaretodorandomeffectsmodel
meta-analyses, yielding summary relative risks and 95%
confidence intervals. All statistical tests were two sided. We
analysed data for basal cell carcinoma and squamous cell
carcinomaseparately.Toinvestigatevariability(heterogeneity)
in study outcomes, we used a χ
2 test for heterogeneity and an I
2
statistic.
WeusedtheSTROBEstatementguidelinestoassessthequality
ofindividualstudies.
31Of16studiesidentified,twodidnotstate
when data was collected,
18 26 three case-control studies did not
match cases and controls,
19 21 28 and three case-control studies
used frequency rather than individual matching.
20 25 27
Additionally, nine studies did not clearly report participation
rates,
15 17 18 19 21 23 26 28 29 and three did not state ages or sexes of
participants.
22 23 26
To assess potential small study effects and publication bias
across studies, we created funnel plots by plotting the effect
found by each study against the inverse of its standard error.
We reviewed the funnel plot visually and used Begg’s rank
correlation test and Egger’s weighted linear regression test for
formal testing. This aimed to investigate the possibilities that
small studies showing no effects may not be published and that
smallstudiesaremorelikelytobedonewithlessmethodological
rigor, leading to inaccurate effect estimates.
We calculated population proportional attributable risk as
(prevalence of exposure×(RR−1))/(1+prevalence of
exposure×(RR−1)), where RR is relative risk. We calculated
this for the United States, for which we had representative data
on both the incidence of NMSC (estimated at 3 507 693 new
cases in 2006
2) and one year prevalence of indoor tanning
(estimated at 13.4% for 2005
32).
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Figure1⇓showsthestudyselectionprocess.Databasesearches
yielded a total of 558 unique publications whose title and
abstract were screened. We discarded 536 because of no
relevance (n=416), no unique data presented (for example,
editorial article or review, n=110), or language other than
English (n=10). We examined the remaining 22 articles in full
text. Sixteen studies met the inclusion criteria and are included
in table 1⇓. We included 12 studies in the quantitative
meta-analysis. Excluded from meta-analysis were one study
that reported only mean numbers of exposures (numbers of
indoor tanning visits),
18 one study that grouped patients with
basalcellcarcinoma,squamouscellcarcinoma,andmelanoma,
24
andtwostudiesthatgroupedbasalcellcarcinomaandsquamous
cell carcinoma together.
23 26 These last two studies also used
patientsadmittedtohospitalwithsolidorgancancerascontrols,
which are unlikely to be representative of the population from
which the cases arose.
23 26 All four studies showed
non-significantassociations,althoughoneshowedastatistically
significant positive association when sunbed exposure was
grouped with medical phototherapy.
24
The 12 studies included in the meta-analysis were published
between 1985 and 2012, used data collected between 1977 and
2010 in six different countries, and included 80 661 total
participants and 9328 cases of NMSC. All 12 studies reported
orprovidedrawdataforeffectestimatesasoddsratiosorhazard
ratios (table 2⇓). When available, we preferentially present
effect estimates reported using multivariate models.
Effect estimates for ever exposure to indoor tanning compared
with never exposure were available for 10 out of 12 studies. A
meta-analysis of these studies yielded summary relative risks
of 1.29 (95% confidence interval 1.08 to 1.53) for basal cell
carcinoma and 1.67 (1.29 to 2.17) for squamous cell carcinoma
(fig2⇓).Aχ
2testforheterogeneitywasnon-significantforboth
basal cell carcinoma (P=0.14) and squamous cell carcinoma
(P=0.09); I
2 statistics were 36.8% (95% confidence interval 0%
to 72%) for basal cell carcinoma and 47.1% (0% to 79%) for
squamous cell carcinoma. To include all available studies, we
did a sensitivity analysis using the effect statistics from all 12
studies,includingthetwostudiesthatreportedonlyhigherdose
exposure.
17 28Bothstudiesconsideredonlybasalcellcarcinoma;
with these two studies included, the summary relative risk for
basal cell carcinoma was 1.25 (1.01 to 1.55). Funnel plots
assessing publication bias were symmetrical for both basal cell
carcinoma and squamous cell carcinoma, and all Begg’s and
Egger’s tests were not statistically significant, suggesting that
publication bias was unlikely. Our results did not change
appreciablyinasensitivityanalysisexcludingfourretrospective
studies that did not fully adjust for confounders.
14 19 21 27
To assess the presence of a dose-response effect, we did a
sub-analysisonstudiesthatincludedeffectestimatesforfrequent
or multiple (high dose) exposures to indoor tanning (table 3⇓,
top). High dose exposure was associated with a relative risk of
1.50 (0.81 to 2.77) for basal cell carcinoma. To assess the
potential effect of exposure to indoor tanning at a young age,
we did a sub-analysis on studies that included effect estimates
for early life exposure (table 3⇓, bottom). Indoor tanning
exposure before age 25 was associated with a relative risk of
1.40 (1.29 to 1.52) for basal cell carcinoma and 2.02 (0.70 to
5.86) for squamous cell carcinoma.
Population attributable risk
Applying our summary risk estimates to the prevalence of
exposure to indoor tanning in the United States, we calculated
the population attributable risk fraction at 3.7% for basal cell
carcinoma and at 8.2% for squamous cell carcinoma. This
corresponds to 98 408 cases of basal cell carcinoma and 72 244
cases of squamous cell carcinoma, making 170 652 cases of
non-melanoma skin cancer each year attributable to indoor
tanning (see supplementary figure).
Discussion
In this systematic review and meta-analysis of more than 9300
cases of non-melanoma skin cancer from 12 studies, we found
apositive,statisticallysignificantassociationbetweenexposure
to indoor tanning and NMSC. Ever exposure to indoor tanning
was associated with a 67% higher risk for squamous cell
carcinoma and a 29% higher risk for basal cell carcinoma.
Exposure to indoor tanning at a young age was significantly
associated with an increased risk for basal cell carcinoma and
showed a non-significant increased risk for squamous cell
carcinoma. High dose exposure to indoor tanning showed a
non-significant increased risk for basal cell carcinoma. This
suggests a critical period for exposure during early life and a
potential dose-response effect.
Possible explanations for findings
AcausallinkbetweenindoortanningandNMSCisonepossible
explanation for our findings. This link is biologically plausible,
because both ultraviolet A and ultraviolet B radiations are
establishedcarcinogensinanimalmodelsandhumanstudies.
11 33
Several population based studies have documented rapid rises
in skin cancer among young women, coinciding with the
adoption of indoor tanning and supporting this causal
relation.
8 34 35 The dose-response effect noted in several studies
further supports this argument.
20 29 The temporal relation in
which indoor tanning at a young age is a stronger risk factor
not only supports a causal interpretation but also implies a
critical period of higher susceptibility during early life.
Alternativeexplanationsforthesefindingsincludethepossibility
that these observational and mostly retrospective studies were
confounded by skin type or outdoor exposure to ultraviolet
radiation. For example, fair skinned people who are more
susceptible to NMSC might use indoor tanning more often, and
indoortannersmayalsogetmoreoutdoorultravioletexposure.
35
Because most of the studies included in the primary
meta-analysis (8/10) controlled for skin type or sun sensitivity
and many (5/10) controlled for outdoor ultraviolet exposure,
we do not feel that this confounding alone could account for
the significant associations observed. Also, differential recall
of use of indoor tanning in people already diagnosed as having
skincancerisaconcernincase-controlstudies.However,given
that prospective cohort studies found similar effect sizes, and
are heavily weighted in this meta-analysis, we do not think that
recall bias significantly affects our conclusion. Although they
are always a concern in literature based meta-analyses,
publication bias and small study effects are unlikely to fully
explain these findings on the basis of our analyses.
Comparison with other studies
These findings are consistent with a previous meta-analysis of
indoor tanning and NMSC,
13 which, using only five studies,
foundasignificantincreaseinriskforsquamouscellcarcinoma
(summary relative risk 2.25, 95% confidence interval 1.08 to
4.70) and a non-significant effect for basal cell carcinoma
(summary relative risk 1.03, 0.56 to 1.90). Our analysis, using
substantially more studies, found a similarly significantly
increased risk for squamous cell carcinoma and, notably, found
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2012;345:e5909 doi: 10.1136/bmj.e5909 (Published 2 October 2012) Page 3 of 9
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findings add to the growing body of evidence on the harms of
indoor tanning. Indoor tanning is already considered a class I
carcinogenonthebasisofitseffectonmalignantmelanoma.
11 12
Although NMSC is generally not a lethal cancer, it affects a
vast number of people worldwide and accounts for a
considerable disease burden.
1 2 6 36 Although the population
attributableriskfractionofindoortanningonNMSCismodest,
when applied to the 3.5 million new cases of NMSC diagnosed
eachyear,indoortanningmayaccountforhundredsofthousands
of new cases each year in the United States alone. Yet this is a
globalproblem:recentstudiesfromAustralia,France,Denmark,
Germany and Sweden suggest that 10.6-35% of people have
used a tanning bed at least once in their lives, and 1.3-29.9%
have done so in the previous year.
37 38 39 40 41 42 43
Limitations of study
This study is limited by the fact that it included only
observational and mostly case-control studies. However, a
randomised trial of indoor tanning is not realistic, and most of
the included studies controlled for multiple potential
confounders, making this the best level of evidence possible.
Another potential limitation of this meta-analysis is the broad
timeperiodspannedbythedata.Includedstudiescollecteddata
fromthe1970stothe2010s,whichisimportantbecauseindoor
tanning devices have changed over time from high ultraviolet
B output to predominately ultraviolet A output.
44 45 46 However,
multiple studies have indicated that both ultraviolet B and
ultraviolet A seem to be capable of causing significant
mutagenic damage to skin.
11 33 47 48
Conclusions
Indoor tanning, which is already an established risk factor for
malignantmelanoma,isprobablyariskfactorforbothsquamous
cell carcinoma and basal cell carcinoma, which are the most
common human cancers. We hope that these findings can
support public health campaigns and motivate increased
regulation to reduce exposure to this carcinogen, especially
during early life.
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RESEARCHWhat is already known on this topic
Non-melanoma skin cancer (NMSC) is the most common human cancer
Indoor tanning is a known risk factor for malignant melanoma, but the data on NMSC are less clear because small individual studies
have resulted in varied effect estimates
What this study adds
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RESEARCHTables
Table 1| Summary of studies
Exposure† % male Age (years) No of cases Total No Diagnosis*
Data
collection Country, year of publication Reference
Studies included in meta-analysis
Ever/never 61.9 43-85 415 830 SCC 2004-05 United States, 2011 Asgari et al
14
Ever/never 65.8 Unknown 92 266 SCC 1977-78 Canada, 1985 Aubry and
McGibbon
15
Ever/never 100.0 25-79 226 BCC; 180
SCC
812 BCC; SCC 1983-84 Canada, 1996 Bajdik et al
16
“Regular”
exposure
40.0 19-40 25 50 BCC 2004-08 Germany, 2011 Bakos et al
17
Ever/never 47.8 ≥18 166 324 BCC 1995-97 Italy, 2001 Corona et al
19
Ever/never 30.8 <40 376 766 BCC 2006-10 United States, 2011 Ferrucci et al
20
Ever/never 41.7 18-80 127 407 BCC 2006-07 Brazil, 2011 Gon and Minelli
21
Ever/never 0.0 43-68 283 BCC; 275
SCC
1362 BCC; SCC 1989-98 United States, 2006 Han et al
22
Ever/never 59.5 25-74 603 BCC 293
SCC
1436 BCC; SCC 1993-95 United States, 2002 Karagas et al
25
Ever/never 52.4 20-75 120 BCC; 25
SCC
290 BCC; SCC 1994-96 Switzerland, 1999 Rosso et al
27
>5 exposures per
year‡
48.1 19-92 213 624 BCC 1997-99 Germany, 2004 Walther et al
28
Ever/never§ 0.0 25-62 5506 BCC; 403
SCC
73 494 BCC; SCC 1989-2009 United States, 2012 Zhang et al
29
Studies not included in meta-analysis
No of exposures 0.0 20-40 30 60 BCC Unknown United States,
2002
Boyd et al
18
Ever/never Unknown Unknown 202 BCC; 194
SCC
792 NMSC 1984-85 Ireland, 1989 Herity et al
23
Ever/never 37.3 10-56 791 BCC; 41
SCC; 15 MM**
4820 Skin cancer¶ 1989 Canada, 1991 Hogan et al
24
“Often” exposed 71.9 Unknown 58 BCC; 63 SCC 242 NMSC Unknown Ireland, 1985 O’Loughlin et al
26
*BCC=basal cell carcinoma; SCC=squamous cell carcinoma of skin; NMSC=non-melanoma skin cancer (BCC and SCC grouped together in publication); skin
cancer (malignant melanoma, BCC, SCC all grouped together in publication).
†Ever/never: measurement of ever exposure to indoor tanning compared with never exposure; “regular” exposure: defined in publication as “regular” exposure to
indoor tanning, with no further specifics; “often” exposed: defined in publication as “often” exposed to indoor tanning, with no further specifics.
‡>5 exposures to indoor tanning per year compared with ≤5 exposures per year.
§Ever/never comparison obtained directly from authors.
¶Skin cancer of head and neck.
**MM=malignant melanoma.
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RESEARCHTable 2| Outcome effect sizes for studies included in primary meta-analysis
Adjustments
Odds ratio (95% CI)
Reference Squamous cell carcinoma Basal cell carcinoma
Studies comparing ever exposure with indoor tanning to never exposure
None (crude) 1.41 (0.90 to 2.22) — Asgari et al
14
Age, sex, eye and hair colour, skin type*, ethnicity,
sun exposure†
13.42 (1.38 to 130.48) — Aubry and McGibbon
15
Age, (sex‡), hair colour, skin type*, ethnicity, sun
exposure†
1.4 (0.7 to2.7) 1.2 (0.7 to 2.2) Bajdik et al
16
Age, sex, skin type*, sun exposure†, family history
of skin cancer
— 0.6 (0.3 to 1.2) Corona et al
19
Age, sex, body site, skin type*, sun sensitivity§, family
history of skin cancer, melanocortin 1 receptor gene
non-synonymous variants
— 1.69 (1.15 to 2.48) Ferrucci et al
20
Age, sex, eye colour, hair colour, skin type*, family
history of skin cancer, presence of actinic keratosis
— 0.31 (0.07 to 1.35) Gon and Minelli
21
Age, (sex‡), sun exposure†, sun sensitivity§, history
of severe sunburns¶, geography**, family history of
skin cancer
1.44 (0.93 to 2.24) 1.32 (0.87 to 2.03) Han et al
22
Age, sex, sun sensitivity§†† 2.5 (1.7 to 3.8) 1.5 (1.1 to 2.1) Karagas et al
25
Age, sex — 1.24 (0.53 to 2.88) Rosso et al
27
Age, (sex‡), hair colour, sun exposure†, sun
sensitivity§, history of severe sunburns¶,
geography**, number of moles on legs, family history
of melanoma
1.50 (1.20 to 1.78)‡‡ 1.29 (1.22 to 1.35)‡‡ Zhang et al
29
Studies measuring higher dose exposure: “regular” exposure
17 or >5 exposures per year
28
Sunscreen use, parents’ sunscreen use, smoking — 25.0 (2.26 to 277.36) Bakos et al
17
None (crude) — 0.7 (0.3 to 1.5) Walther et al
28
*Skin type: complexion (Aubry and McGibbon), skin colour (Bajdik et al, Ferrucci et al), pigmentary traits (Corona et al).
†Sun exposure: non-occupational sun exposure (Aubry and McGibbon), lifetime occupational sun exposure (Bajdik et al), number of weeks spent at beach before
age 20 and outdoor work (Corona et al), cumulative sun exposure while wearing bathing suit (Han et al), outdoor sun exposure (Zhang et al).
‡Study not adjusted for sex because only included one sex.
§Skin sensitivity to sun: skin response to first exposure of season to 1 hour of summer sun and to prolonged exposure to sun (Ferrucci et al), constitutional
susceptibility score (Han et al), sun sensitivity (Karagas et al), childhood tendency to sunburn (Zhang et al).
¶History of severe sunburns: lifetime sunburns which blistered (Han et al), number of severe sunburns between 15 and 20 (Zhang et al).
**Geography: geographic region at baseline (Han et al), ultraviolet index in area of residence at birth and 15 and 30 years of age (Zhang et al).
††Adjusted for age and sex in basal cell carcinoma analysis because adjustment for sun sensitivity did not change results.
‡Hazard ratio (95% CI), obtained directly from authors.
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RESEARCHTable 3| Outcome effect sizes for studies included in subset analyses of high dose exposure and young age at exposure
Odds ratio (95% CI)
Exposure/age Reference Squamous cell carcinoma Basal cell carcinoma
Studies assessing high dose exposure to indoor tanning
— 25.0 (2.26 to 277.36) “Regular use of tanning beds in lifetime” Bakos et al
17
— 2.16 (1.34 to 3.48) 6-26 years of “regular”’ exposure Ferrucci et al
20
— 0.7 (0.3 to 1.5) >5 exposures per year Walther et al
28
1.15 (1.01 to 1.31)* 1.15 (1.11 to 1.19)* 4 exposures per year Zhang et al
29
1.50 (0.81 to 2.77) Summary relative risk
Studies assessing young age at exposure to indoor tanning
— 1.83 (1.12 to 2.97) ≤16 years of age Ferrucci et al
20
3.66 (1.9 to 6.9) 1.8 (1.0 to 3.0) <20 years of age Karagas et al
25
1.21 (0.85 to 1.71)† 1.38 (1.27 to 1.5)† “High school/college” Zhang et al
29
2.02 (0.70 to 5.86) 1.40 (1.29 to 1.52) Summary relative risk
*Hazard ratio (95% CI).
†Hazard ratio (95% CI) obtained directly from authors.
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RESEARCHFigures
Fig 1 PRISMA flow diagram of literature search and study selection for meta-analysis of indoor tanning and non-melanoma
skin cancer. BCC=basal cell carcinoma; NMSC=non-melanoma skin cancer; SCC=squamous cell carcinoma
Fig 2 Relative risk of basal cell carcinoma and squamous cell carcinoma in participants ever exposed to indoor tanning
compared with participants never exposed to indoor tanning
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